- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed or Refractory EBV-and CD30-positive Lymphomas
Total 937 results
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedEpstein-Barr Virus-Related Hodgkin Lymphoma | Epstein-Barr Virus-Related Non-Hodgkin Lymphoma | EBV Positive Plasma Cell NeoplasmUnited States
-
Lapo AlinariRecruitingRecurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC... and other conditionsUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedRelapsed/Refractory Hodgkin's LymphomaItaly
-
Brian HillRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
AmgenCompletedRelapsed/Refractory Philadelphia Positive B-precursor ALLFrance, United States, Germany, Italy, United Kingdom
-
ImmunityBio, Inc.RecruitingNon Hodgkin's Lymphoma Refractory/RelapsedUnited States
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
AHS Cancer Control AlbertaTom Baker Cancer CentreTerminatedFollicular Lymphoma | Hodgkin's Lymphoma - Relapsed/Refractory | Non-Hodgkin's Lymphoma - AggressiveCanada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Small Lymphocytic Lymphoma | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia and other conditionsUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingRelapsed and Refractory B-cell LymphomaChina
-
Navy General Hospital, BeijingRecruitingRefractory Classic Hodgkin Lymphoma | Relapsed Classic Hodgkin LymphomaChina
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.Not yet recruitingRelapsed or Refractory DLBCL
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaChina
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory Mantle Cell LymphomaUnited States, Netherlands, Germany, France
-
Joseph TuscanoSpectrum Pharmaceuticals, IncActive, not recruitingRelapsed Non Hodgkin Lymphoma | Refractory Non Hodgkin LymphomaUnited States
-
GC Cell CorporationUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Loyola UniversityCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Chinese PLA General HospitalShenzhen University General Hospital; Shenzhen UniversityUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
Fondazione Italiana Linfomi - ETSRecruitingRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaItaly
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
Chongqing Precision Biotech Co., LtdRecruitingNon Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
BeiGeneCompletedRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaChina
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States
-
Cellular Biomedicine Group Ltd.RecruitingRelapsed/Refractory Large B-Cell LymphomaChina
-
Kite, A Gilead CompanyHumanigen, Inc.TerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownRelapsed / Refractory Mantle Cell Lymphoma (MCL)China
-
National Cancer Center, KoreaRecruitingRelapsed/Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Classical Hodgkin's LymphomaChina
-
Huiqiang HuangGuangdong 999 Brain HospitalNot yet recruitingNon Hodgkin Lymphoma | PCNSL | Refractory and Relapsed Primary CNS LymphomaChina
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
Stanford UniversityMerck Sharp & Dohme LLCSuspendedHodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin LymphomaUnited States
-
Mustang BioNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Acute Leukemia | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Systemic Mastocytosis | Recurrent Hematologic Malignancy | Hairy Cell Leukemia | Chronic... and other conditions
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.CompletedT-cell Lymphoma | Relapsed and Refractory T-cell LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower... and other collaboratorsRecruiting
-
Shanghai Unicar-Therapy Bio-medicine Technology...The First Affiliated Hospital of Soochow UniversityRecruitingAcute Lymphoblastic Leukemia | Relapse | CD19 Positive | RefractoryChina
-
UNC Lineberger Comprehensive Cancer CenterAmerican Society of Clinical OncologyRecruitingRefractory Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaSpain